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The kidney has a high capacity to regenerate after ischemic injury via several mechanisms, one of which
involves bone marrow-derived (stem) cells. The ATP binding cassette transporters, P-glycoprotein and breast
cancer resistance protein, are determinants for the enriched stem and progenitor cell fraction in bone marrow.
Because they are upregulated after acute kidney injury, we hypothesized that both efflux pumps may play a
role in protecting against renal injury. Surprisingly, transporter-deficient mice were protected against ische-
mia-induced renal injury. To further study this, bone marrow from irradiated wild-type mice was reconstitu-
ted by bone marrow from wild-type, P-glycoprotein- or breast cancer resistance protein-deficient mice. Four
weeks later, kidney injury was induced and its function evaluated. Significantly more bone marrow-derived
cells were detected in kidneys grafted with transporter-deficient bone marrow. A gender mismatch study
suggested that cell fusion of resident tubular cells with bone marrow cells was unlikely. Renal function
analyses indicated an absence of renal damage following ischemia-reperfusion in animals transplanted with
transporter-deficient bone marrow. When wild-type bone marrow was transplanted in breast cancer resistance
protein-deficient mice this protection is lost. Furthermore, we demonstrate that transporter-deficient bone
marrow contained significantly more monocytes, granulocytes, and early outgrowth endothelial progenitor
cells.
Key words: Bone marrow transplantation; Ischemia-reperfusion injury; Renal function; Side population;
ABC transporter
INTRODUCTION (2,11). However, EMT may also lead to renal fibrosis
(13), eventually compromising renal function. Finally,
bone marrow (BM) cells may play a role in renal regen-Acute kidney injury (AKI) is a frequent clinical prob-
lem with a high mortality, affecting many patients, par- eration. Within the BM, several stem cell populations
with pluripotent characteristics, viz. the multipotentticularly in the intensive care unit. Nevertheless, the
proximal tubular epithelium, mostly affected after in- adult progenitor cells (MAPC), the hematopoietic stem
cell population (HSC), the ckit+, Sca-1+, lin− (KSL) sub-jury, has a high capacity to regenerate. Surviving tubular
cells can proliferate and spread to the place of injury population, and mesenchymal stem cells (MSC), may
aid in renal regeneration (17,29,35,37,38,40). A key fea-to repair the damaged epithelium. In addition, resident
tubular cells may dedifferentiate into a more primitive ture of these stem cells, and especially of the side popu-
lation (SP) comprising 73% of the KSL subpopulationmesenchymal phenotype, thought to serve as resident
stem cells in the kidney, and repair the damage via a in HSC (5), is their expression of two efflux pumps,
P-glycoprotein (P-gp), the multidrug resistance gene 1process called epithelial-to-mesenchymal transition (EMT)
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(MDR1) product, and breast cancer resistance protein 1 procedures. Male, WT, Friend leukemia virus B strain
mice (FVB) (6–8 weeks) were obtained from Charles(BCRP).
P-gp/ABCB1 and BCRP/ABCG2 belong to the super- River (Germany), and were housed under routine labora-
tory conditions at the Central Animal Facility Nijmegen.family of ATP binding cassette (ABC) transporters and
are expressed mainly in excretory organs, such as the P-gp-deficient (mdr1a/1b−/−) or BCRP-deficient (bcrp−/−)
mice (6–8 weeks; FVB background) were bred andliver, intestine, and the kidney. Localization studies re-
vealed that within the kidney both efflux pumps are ex- housed in Nijmegen. For the collection of blood and
urine, mice were individually housed in metabolic cagespressed at the apical membrane of renal proximal tubule
cells (20,46). ABC transporters protect against accumu- (Techniplast, Exton, USA) as described previously
(20,21). Mice were allowed to adapt to these cages forlation of xenobiotics and other potentially toxic sub-
stances. Moreover, BCRP protects progenitor cells un- 1 day, and after a rest period of 1 day, 24-h urine sam-
ples were collected. Mice were injected intraperitoneallyder hypoxic conditions by reducing the accumulation of
detrimental products like heme and porphyrin (32). Both 0.5 ml of 0.9% NaCl (B. Braun Melsungen AG, Mel-
sungen, Germany) in order to maintain a normal fluidtransporters have been implicated in tissue regeneration,
as P-gp expression is increased in severe human liver balance. Food and water were available ad libitum. AKI
was applied by bilateral clamping in BCRP-deficientdisease (43) and expression of BCRP increases follow-
ing stroke (8). In the kidney, differential expression of mice as described previously (21). In transplantation
studies we applied unilateral ischemic renal injury byP-gp and BCRP is detected during pathological circum-
stances. Cadmium- and endotoxin-mediated renal dam- clamping the left renal artery and vein for 30 min, 4
weeks after transplantation of BM cells. The bilateralage is associated with elevated levels of P-gp (19,45),
and P-gp and BCRP expression increase after ischemic clamping is most effective; however, inducing bilateral
ischemic injury in transplanted FVB mice is near-to-renal injury in mice (24).
P-gp and BCRP may regulate hematopoietic develop- fully lethal, as these mice are also recovering from irra-
diation that induces renal injury (39). Blood and urinement. When constitutively expressed, BCRP stimulates
the growth potential of human (hematopoietic) clono- were used for standard clinical chemistry analyses;
serum and urine creatinine levels were measured bygenic progenitor cells (1). On the other hand, expression
of human BCRP in murine BM cells increased the SP HPLC (12). The fractional excretion of sodium was cal-
culated according to the following equation: FENa = 100 ×population and blocked maturation (52), whereas en-
forced expression of P-gp in murine HSC resulted in a (Naurine × creatinineplasma)/Naplasma × creatinineurine).
To characterize proximal tubular function we injectedmarked expansion of repopulating cells and a myelopro-
liferative disease (6). Loss of expression of P-gp in mu- 16 mice subcutaneously with 10 mmol/kg body weight
of lithium chloride (Merck, Darmstadt, Germany). Afterrine BM resulted in an increased SP fraction, possibly
due to compensatory upregulation of BCRP. However, collecting blood from all mice before injection, mice
were divided in groups of four and blood was collectedloss of the abcg2 gene led to a reduction in the number
of SP cells (51). 1, 3, 6, and 8 h after injection. Lithium concentrations
were determined in serum according to the method de-We hypothesized that if BM-derived cells aid in renal
repair following ischemia-reperfusion, and if P-gp and scribed by Tabata et al. (44).
BCRP play a role in renal repair, deficiency of P-gp or
Transduction of Primary Mouse BM CellsBCRP in BM cells will lead to a decreased recovery in
renal function following ischemia-reperfusion. To inves- Chemicals and cytokines were obtained from Sigma
(Zwijndrecht, The Netherlands), unless stated otherwise.tigate this, BM from irradiated wild-type (WT) mice was
reconstituted by transplanting BM from WT, P-gp-defi- BM was harvested from the femurs, and cells were cul-
tured at 37°C, 5% CO2 for 2 days in IMDM mediumcient, or BCRP-deficient mice. Four weeks later, kidney
injury was induced and after 7 days its function was (Invitrogen, Life Technologies, Breda, The Netherlands)
supplemented with 10% fetal calf serum (Integro, Zaan-assessed, and, subsequently, kidneys were evaluated for
the number and phenotype of BM-derived cells present. dam, The Netherlands), 1% penicillin (5000 U) and
streptomycin (5 mg/ml) solution (Invitrogen), 7 µl/LSurprisingly, we found that P-gp or BCRP deficiency in
BM resulted in improved renal outcome following ische- β-mercaptoethanol, 1% bovine serum albumin, 1% nu-
cleoside mix (0.1 mg/ml cytidine, adenosine, uridine,mia-reperfusion injury.
guanosine, 2′-deoxycytidin, 2′-deoxyadenosine, thymi-
MATERIALS AND METHODS dine, 2′-deoxyguanosine), 10 µg/ml bovine insulin (In-
Animals vitrogen), 15 µM cholesterol, 15 µM linolic acid, 0.62
mg/ml human transferring, and the following recombi-The animal ethics board of the Radboud University
Nijmegen Medical Centre approved all experimental nant cytokines: murine stem cell factor 50 ng/ml, murine
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interleukin (IL)-12 10 ng/ml, murine IL-3 10 ng/ml, hu- 1:100; C219, Dako Diagnostics BV, Herverlee, Bel-
gium) in PBS, 0.5% BSA for 1 h at room temperature.man FMS-like tyrosine kinase 3 (Flt-3) 50 ng/ml, human
thrombopoeitin 10 ng/ml (ITK Diagnostics, Uithoorn, Next, slices were washed three times with PBS and in-
cubated with the secondary antibody: goat anti-mouseThe Netherlands), anti-TGF-β 1 µg/ml (ITK Diagnos-
tics). Cells were plated onto retronectin-coated culture Alexa Fluo 488 was used for GFP, goat anti-rabbit
Alexa Fluo 594 for Ter-199/Ly-76 and P-gp, and goatdishes (Takara, Cambrex Bio Science, Heerhugowaard,
The Netherlands) and exposed to the supernatant of anti-rat Alexa Fluo 594 for BCRP, all diluted 1:200 in
PBS/0.5% BSA. Sections were examined using a confo-packaging, ecotropic Phoenix cells, transfected with ret-
roviral vector pLZRS encoding for enhanced green fluo- cal laser-scanning microscope (CLSM; Leica lasertech-
nik GmbH, Heidelberg, Germany). Renal tubule cellsrescent protein (eGFP) (16,18). Twenty-four hours after
exposure to the retroviral vector, cells were collected that originated from transduced BM cells were calcu-
lated 7 days after the injury by staining with antibodiesand eGFP-positive cells selected using an Epics Altra
flow cytometer (Beckman Coulter, Miami, FL, USA). directed against GFP and applying confocal microscopy.
For semiquantification, a single green cell in the kidney
Irradiation and Transplantation cortex counted for a positive tubule. Data are expressed
as percent of total number of tubules.Mice were irradiated with a single dose of 3.5 Gy
(6 MV) using a Digital Precise SLi Linear Accelerator
Fluorescence In Situ Hybridization(Elekta, Crawley, UK) and subsequently 106 eGFP-posi-
tive BM cells, diluted in 100 µl 0.9% NaCl (B. Braun Fluorescence in situ hybridization was performed us-
ing a mouse whole chromosome X [fluorescein-isothio-Melsungen AG) were injected via the tail vein. After
transplantation, mice were housed under semisterile con- cyanate (FITC) labeled; green) and Y [cyanine-3 (Cy3)
labeled; red] painting (Cambio, Cambridge, UK) accord-ditions to avoid infections. The amount of eGFP-posi-
tive cells in the circulation was measured by fluores- ing to de Bruijn et al. (9). In brief, 4-µm-thick sections
of perfused frozen mouse kidney from WT-WT gendercence-activated cell sorting (FACS) 24 h after induction
of ischemia-reperfusion injury. After collecting blood mismatch transplantations were pretreated with pepsine
(Sigma), prefixed in 70% ethanol at −20°C, washed withfrom the retro-orbital sinus, erythrocytes were lysed and
the amount of eGFP-positive cells in the peripheral Nonidet P40 (Fluka, Sigma-Aldrich, Buchs, Switzer-
land), and dehydrated. An amount of 3 µl of each chro-blood was determined.
mosome paint was used in a total of 10 µl hybridization
Histology and Semiquantification mix (Cambio) and administered under a coverslip of
of Morphometric Analysis 20 × 20 mm and denatured simultaneously on a Hybaid
Omnislide (Thermo Electron, Milford, MA, USA). Post-For light microscopy, kidney fragments were fixed in
Bouin’s solution, dehydrated, and embedded in paraplast hybridization was performed by a wash step of 0.4 SSC/
Tween-20 at 68.5°C followed by several steps of 2×(Amstelstad, Amsterdam, The Netherlands); sections of
3 µm were stained with periodic acid-Schiff. The renal SSC, 4× SSC, and PBS at room temperature. After de-
hydration slides were counterstained with DAPI (Vec-sections were examined for abnormalities and the num-
ber of pycnotic nuclei was semiquantitatively calculated. tor) and eGFP, and 100 eGFP-positive cells were ana-
lyzed. A Zeiss Axiophot-2 microscope (Zeiss, Germany)Nuclear alteration, such as pycnosis, generally is consid-
ered a reflection of reduced vital cellular functions. Im- equipped with appropriate fluorescence filters was used
for qualitative analysis of the fluorescence signals. Theages of 768 × 573 pixels were analyzed and the number
of condensed nuclei of cells undergoing apoptosis was specimen was scanned for clearly recognizable individ-
ual cells to facilitate reliable scoring of the chromosomecounted for each image.
paintings. Images were captured by a Leica DC 350FX
Immunohistochemistry and Quantification of Renal camera using Leica CW4000 software package (Leica,
Tubules From Donor Origin Germany).
For immunohistochemistry, kidney fragments were
Western Blot Analysissnap frozen in liquid nitrogen and 2-µm cryostat sec-
tions were used. Sections were fixed in acetone for 10 Total renal fractions of six pooled kidneys were ob-
tained using the micro-dismembrator (Sartorius BBImin and air dried. Slices were incubated with primary
antibodies against GFP (diluted 1:200, Roche Diagnos- Systems GmbH, Melsungen, Germany). To this end,
perfused frozen kidneys were pulverized (2000 rpm, 30tics, Basel, Switzerland), Ter-119/Ly-76 (diluted 1:200),
MAC-1 (diluted 1:200, Becton Dickinson, Breda, The s) and transferred to ice-cold TS buffer (10 mM Tris-
HCl, 250 mM sucrose) containing protease inhibitors (1Netherlands), BCRP (diluted 1:50; BXP-9, Kamiya Bio-
medical Systems, Seattle, WA, USA), or P-gp (diluted mM phenylmethylsulfonyl fluoride, 1 µg/ml aprotinin, 5
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µg/ml leupeptin, 1 µg/ml pepstatin, and 10 µM E64). of a one-way ANOVA followed by Bonferroni’s multi-
ple comparison test. Software used for statistical analy-These suspensions were centrifuged for 12,000 × g, 30
min, 4°C and the resulting supernatant contained the to- sis was Graphpad Prism (version 4.03 for Windows;
Graphpad Software, San Diego, CA, USA).tal fraction. From these fractions, 50 µg was solubilized
in Laemmli sample buffer, heated at 65°C for 10 min,
RESULTSseparated on a 10% sodium dodecyl sulfate (SDS)-poly-
BCRP-Deficient Mice Are Protected Againstacrylamide gel, and transferred to Hybond-C pure nitro-
Ischemic Renal Injurycellulose membrane. Analysis was performed by the Od-
yssey infrared imaging system (LI-COR, Biosciences, Renal function in BCRP-deficient animals was evalu-
NE, USA). The membrane was blocked in Odyssey ated following an ischemic insult of bilateral clamping
blocking buffer diluted 1:1 with PBS for 1 h at room of the renal arteries and veins for 30 min. Wild-type
temperature. Subsequently, the membrane was incubated animals followed a typical pattern of reversible renal
overnight with the primary antibodies at 4°C: GFP (1: damage (24), characterized by a decrease in creatinine
200; Invitrogen, Breda, The Netherlands) and β-actin (1: clearance 2 days after ischemia and restoration to near
100,000; Sigma, Zwijndrecht, The Netherlands) diluted normal levels by day 7. In contrast, creatinine clearance
in PBS supplemented with 0.1% Tween-20 and 0.01% increased in BCRP-deficient mice during the 7 days
SDS. After three washing steps of 10 min in PBS, the after ischemia (Fig. 1A). These findings were confirmed
blot was incubated in the dark at room temperature for by renal histology (Fig. 1B, C), where signs of tubular
60 min with the secondary antibody in PBS 0.1% damage (pycnotic nuclei, cell blebbing, brush border
Tween-20; IRDye 800 anti-rat and IR-Dye 800 anti- loss), apparent 2 days after injury, in WT mice were
mouse (Rockland Immunohistochemistry Inc., Gilberts- not present in kidneys from BCRP-deficient animals. In
ville, USA). After repeating the washing steps images addition, renal functional parameters were determined
were acquired with the Odyssey infrared imaging system (summarized in Table 1) and demonstrated increased
and analyzed by the software program as specified in urine flow and slightly elevated creatinine and inulin
the Odyssey software manual. For semiquantification, clearances (defining the glomerular filtration rate, GFR)
we measured the pixel intensity of the bands using Scion in these knockout mice. Importantly, the BCRP-defi-
image version beta 4.02 for Windows (Scion Corp., cient mice show normal proximal tubular function as
Frederick, MD, USA). determined by the fractional excretion of sodium and
lithium clearance.
BM and Early Endothelial Progenitor
Cell Characterization Deficiency of P-gp or BCRP in BM-Derived But Not
in Resident Cells Protects Against Ischemic InjuryBM cells were isolated as described above and eryth-
rocytes were lysed. After centrifugation, BM was To investigate whether the protection against AKI
observed in P-gp- and BCRP-deficient mice is a resultwashed and fractions were stained with the following
conjugated antibodies: Sca-1, c-kit, Thy1.1, Ter 119, of the transporter deficiency in BM, we first set up an
experimental model of BM engraftment in AKI (23).CD45.1, CD45.2, Mac-1, Gr-1, CD4, CD8, CD19,
B220, CD31, CD34, and isotype controls (BD Biosci- eGFP-transduced BM cells derived from WT, BCRP-
deficient, or P-gp-deficient mice were transplanted intoences, Alphen a/d Rijn, The Netherlands). Thereafter,
BM cells were analyzed using FACS to determine cell WT mice. Four weeks later, unilateral ischemia was in-
duced and renal function was evaluated at different timesurface phenotype. Early outgrowth endothelial progeni-
tor cells (EPCs) were isolated from spleens of adult mice points thereafter. Wild-type mice grafted with WT BM
(WT-WT) showed decreased creatinine clearance 2 days(six per genotype) and cultured according to Yoder et
al. (50). Early endothelial outgrowth was scored by in- after ischemia (Fig. 2A), which returned to near normal
levels on day 7, consistent with nontransplanted micecubating the cells with DiI-acetylated low density lipo-
protein (AcLDL; Biomedical Technical Inc., Stoughton, (Fig. 1A). In contrast, animals transplanted with P-gp-
deficient BM (P-gp-WT) had increased creatinine clear-USA), staining with FITC-Bandeiraea Simplicifolia
(BS)-I lectin (Sigma, Belgium), and counting the num- ances 2 days after injury (p < 0.05), which returned to
baseline after 7 days (Fig. 2A). Animals transplantedber of double positive cells for each well. Results were
expressed as the average number of double positive cells with BCRP-deficient BM (BCRP-WT) showed a com-
parable increase in creatinine clearance (p < 0.05), butper area (in cm2).
this remained elevated after 7 days (Fig. 2A), similar to
Data Analysis BCRP-deficient mice (Fig. 1A). Furthermore, fractional
excretion of sodium (FENa) was calculated to determineData are presented as means ± SEM. Mean values
were considered to be significant when p < 0.05 by use renal tubular function. Two days after ischemia, solely
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Figure 1. BCRP-deficient mice are resistant to renal ischemia. AKI was applied by bilateral clamping of renal arteries and veins
for 30 min. (A) Renal function, measured as creatinine clearance in BCRP-deficient mice (open circles) compared to wild-type
(WT) animals (filled circles), at baseline (0), 2, and 7 days after ischemia. Data are expressed as mean ± SEM of six mice. ***p <
0.001 compared to WT; ###p < 0.001 compared to baseline WT. (B) Representative histological images in WT and BCRP-deficient
(bcrp−/−) mice at baseline (0), 2, and 7 days after ischemia. Pronounced renal tubular epithelial cell detachment from the basement
membrane (cell debris) into the tubular lumen was observed in WT mice, whereas such an effect was absent in BCRP-deficient
mice. Original magnifications: ×200, ×400. (C) For semiquantification, the number of pycnotic nuclei was calculated. Data are
expressed as mean ± SEM of 3–7 kidneys (bcrp−/− baseline: n = 3; WT baseline: n = 4; bcrp−/− day 2: n = 3; WT day 2: n = 4; bcrp−/−
day 7: n = 4; and WT day 7: n = 7). ***p < 0.001 compared to BCRP-deficient animals.
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Table 1. Renal Characteristics of BCRP-Deficient Mice creased as compared to WT-WT transplanted animals,
Compared to WT Mice p < 0.05). This was confirmed by histology (Fig. 3B),
because severe tubular alterations were observed compa-
BCRP
rable to WT mice transplanted with WT BM (Fig. 2B).WT (n) Deficient (n)
These findings corroborate that absence of BCRP in BM
cells, but not in resident cells, is beneficial for the kid-Urine volume (ml/24 h) 0.75 ± 0.03 (42) 3.4 ± 1.1* (41)
Creatinine clearance ney after injury.
(µl/min) 493 ± 107 (5) 569 ± 35† (6)
GFR (µl/min) 405 ± 29 (4) 700 ± 200* (4) ABC Transporter-Deficient BM Engraftment Into WT
FEsodium (%) 0.093 ± 0.008 (4) 0.095 ± 0.017 (6) Mice Results in Protection From AKI
Lithium clearance The level of engraftment of BM-derived cells in renal(µl/min) 104 ± 3 (8) 98 ± 15 (8)
tubular cells in mice is small and varied, and literature
Data are presented as mean values ± SEM. WT, wild type; GFR, glo- values between 3% and 8% were reported (14,40). We
merular filtration rate determined by [methoxy-3H]inulin clearance as investigated the number of BM-derived cells present indescribed previously (21); FEsodium, fractional excretion of sodium.
the injured kidneys after transplantation of P-gp- or*p < 0.001 compared to WT animals.
†p < 0.05 compared to WT animals. BCRP-deficient BM. To avoid false-positive results,
confocal microscopy of eGFP staining with antibodies
against GFP combined with other markers was applied.
In WT BM grafted animals, few BM-derived cells werethe WT BM grafted animals had a significant increased
FENa, despite the fact that they were within normal seen 2 days following the injury, but on day 7 BM cells
were detectable throughout the kidney (Fig. 4A). In P-range, returning to baseline after 7 days. In line with the
creatinine clearances the FENa did not change in animals gp-deficient grafted animals, however, infiltration of
eGFP-positive cells was already seen 2 days after ische-transplanted with P-gp-deficient or BCRP-deficient BM
(Fig. 2A). mia and their number increased further after 7 days. To
confirm the BM origin of infiltrating cells, tissues wereHistological analysis (Fig. 2B, C) confirmed the ab-
sence of renal damage following ischemia-reperfusion counterstained with an antibody against P-gp, demon-
strating that eGFP-positive cells did not express thein WT animals transplanted with BM deficient of P-gp
or BCRP. Animals grafted with WT BM showed signifi- ABC efflux pump (Fig. 4A). In BCRP-deficient BM
grafted animals infiltration of eGFP-positive cells wascant damage with a loss of brush border membranes and
obstruction of the tubular lumen on day 2. By day 7, even more pronounced (Fig. 4A, B). Western blot analy-
sis supported the increased infiltration of eGFP-positivesigns of recovery were observed. Kidneys of mice
grafted with BCRP-deficient or P-gp-deficient BM cells in BCRP-deficient or P-gp-deficient grafted ani-
mals (Fig. 4C). Infiltration of eGFP positive cells in theshowed intact brush border membranes and no tubular
obstruction after injury. contralateral kidneys was negligible (data not shown).
Counterstaining with an erythrocyte marker clearlyTo further substantiate the role of the ABC trans-
porter BCRP on BM-derived cells in renal regeneration, showed the localization of peritubular capillaries and
glomeruli, which were not eGFP positive. We nextwe transplanted eGFP-transduced WT BM in BCRP-
deficient mice (WT-BCRP). Four weeks later, renal is- quantified the amount of eGFP-positive tubules in WT-
WT, P-gp-WT, and BCRP-WT 7 days after the injurychemia was established. Creatinine clearance and FENa
(Fig. 3A) were decreased on day 2 after the injury, but using confocal microscopy (Fig. 4B). Significantly more
eGFP-positive cells were detected in kidneys of WTreturned to baseline after 7 days without changing the
renal phenotype (viz. urine flow still significantly in- mice grafted with P-gp-deficient (21.1 ± 2.1%; p < 0.01)
FACING PAGE
Figure 2. Kidneys of WT mice are protected against ischemia after transplantation of BM from P-gp- and BCRP-deficient mice.
(A) Effects of renal ischemia reperfusion on creatinine clearance (left panel) and fractional excretion of sodium (right panel) in
BCRP-WT (open circles), P-gp-WT (open squares), and WT-WT (filled circles) transplanted animals, 0, 2, and 7 days after ische-
mia. Data are expressed as mean ± SEM of 4–8 mice. *p < 0.05 compared to WT-WT; ##p < 0.01, ###p < 0.001 compared to
baseline WT-WT. (B) Representative histological images confirm changes in renal function. G, glomerulus; PT, proximal tubules
with cellular debris. Black arrows indicate brush border membranes (original agnifications: ×200, ×400). (C) For semiquantification,
the number of pycnotic nuclei was calculated. Data are expressed as mean ± SEM of 4–8 kidneys (baseline: WT-WT, n = 4; P-gp-
WT, n = 4; BCRP-WT, n = 6; day 2: WT-WT, n = 6; P-gp-WT, n = 4; BCRP-WT, n = 6; day 7: WT-WT, n = 6; P-gp-WT, n = 8;
BCRP-WT, n = 8). **p < 0.01 compared to BCRP-deficient animals.
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Figure 3. BCRP-deficient mice are not protected against renal AKI after transplantation with BM from WT mice. (A) Effects of
renal ischemia reperfusion on creatinine clearance (left panel) and fractional excretion of sodium (right panel) in WT-BCRP
transplanted animals, 0, 2, and 7 days after ischemia. Data are expressed as mean ± SEM of 8 mice. *p < 0.05 compared to baseline
(Fig. 2A). (B) Representative histological images at baseline (0), 2, and 7 days after ischemia. Pronounced renal tubular epithelial
cells detachment from the basement membrane (cell debris) into the tubular lumen was observed in BCRP-deficient mice trans-
planted with WT BM, comparable to the effect observed in WT-WT transplantations (Fig. 2B, upper panels) (original magnifica-
tions: ×200, ×400).
or BCRP-deficient (28.6 ± 2.8%; p < 0.001) BM com- Increased Numbers of Mononuclear Cells
and Early Outgrowth Endothelial Progenitorpared to WT transplantations (9.6 ± 2.1%).
Cells in BM of P-gp- and BCRP-Deficient Mice
Possibility of Fusion of BM-Derived Cells
To understand how BM from P-gp- or BCRP-defi-With Resident Renal Tubular Cells
cient mice may accelerate renal outcome, we investi-
gated the BM composition of these mice by FACS anal-Transdifferentiation of BM-derived cells may occur,
at least in part, due to fusion between HSC-derived ysis. A significantly increased proportion of monocytes
(CD45+, MAC-1+) and granulocytes (CD45+, Gr-1) weremonocytes and target tissues. We performed gender mis-
match transplantations with donor WT BM cells from present in both strains (Table 2), most pronounced in P-
gp-deficient mice. In addition, the frequency of earlyfemale mice in sublethally irradiated WT male mice.
After 4 weeks ischemia was induced by unilateral outgrowth endothelial progenitor cells (EPCs), which
were shown to be of monocytic origin (50), was deter-clamping. We found female donor cells engrafted in the
tubules of the male kidney after AKI (Fig. 4D). The mined after AcLDL uptake and BS-I lectin staining. We
found higher frequencies in P-gp-deficient (237 ± 120;eGFP-positive cells were exclusively XX and we did not
find any eGFP-positive cells containing a Y chromo- p = 0.07) and BCRP-deficient (110 ± 28; p < 0.05) mice
than in WT mice (42 ± 9). Quantitative RT-PCR analy-some.
P-GLYCOPROTEIN AND BCRP IN RENAL PROTECTION 1203
sis of the EPCs demonstrated high expression levels of show normal creatinine clearances but decreased GFR
[see Table 1 and (21)]. Moreover, the BCRP-deficientCD45, suggesting their hematopoietic origin, and similar
levels of endothelial transcripts, indicating a numerical mice have normal proximal tubular function. The ob-
served hyperfiltration in BCRP-deficient mice comparedbut not qualitative difference (not shown). These find-
ings indicate that the increased amount of monocytes to WT may be characterized as a compensatory response
of remaining functional nephrons after the ischemic in-and granulocytes and the higher frequency of early out-
growth EPCs in BM of both knockout mice were in- jury, helping to maintain renal function.
We further demonstrate that adoptive transfer of P-volved in the protection against AKI, as observed in
transplantation studies with this BM. An increased gp- or BCRP-deficient BM to WT kidneys by grafting
mimics the observations in the transporter-deficientamount of MAC-1-positive cells observed in recipient
kidneys transplanted with knockout BM compared to mice, and that adoptive transfer of WT BM in BCRP-
deficient mice results in a loss of this protective effect.WT transplanted animals 7 days after renal injury fur-
ther confirms increased monocyte infiltration (Fig. 4E). This remarkable protective phenomenon is likely due to
enhanced BM engraftment in absence of P-gp or BCRP,The KSL population in P-gp- and BCRP-deficient mice
was comparable to WT mice (Table 2), suggesting that although conflicting observations concerning the role of
BM in renal tubular regeneration have been reported.the SP population does not contribute to the protective
effect. Transdifferentiation of BM cells to functional tubular
epithelium has been demonstrated previously (14,29,31);
DISCUSSION however, beneficial effects of BM transplantations may
have been accelerated by irradiation of mice prior toIn this study, we show that an absence of the efflux
pumps, P-gp or BCRP, on BM cells results in protection transplantation and kidney damage due to enhanced in-
jury (15,30). Others showed that BM cells may improveagainst renal ischemia-reperfusion injury. This effect
cannot be explained by the function of these transporters renal function without direct involvement in tubular epi-
thelial engraftment (4). The observations in the latterin the kidney, because the knockout mice differ in renal
physiology. Moreover, transplantation of BCRP-defi- study suggested that BM cells may predominantly con-
tribute to the interstitial myofibroblast pool. In contrast,cient mice with WT BM results in an attenuation of pro-
tection without changing kidney physiology. This is the BM cells have also shown not to improve renal function
despite their tubular engraftment (36).first report describing such explicit role of P-gp and
BCRP in renal protection by BM-derived cells. The controversy in the literature may arise from vari-
ations in experimental models and various trackingBoth ABC transporters have been implicated in mul-
tidrug resistance and tissue defense (22). BCRP is ex- methods used to characterize the BM-derived cell phe-
notype (e.g., transgenic reporter gene labeling of donorpressed in plasma membranes of different tissues with
an important barrier function, such as the apical mem- BM with GFP or Lac-Z and/or gender mismatch). Our
gender mismatch studies confirmed engraftment of do-brane of the small and large intestine, the canalicular
membrane of hepatocytes, the mammary gland, the lu- nor BM cells and, moreover, suggest that the mechanism
of BM cell conversion into renal cells after AKI mayminal membrane of the capillary endothelium of brain,
and in the brush border membrane of the placenta (33). not involve cell fusion between resident tubular cells
and donor BM cells, although we cannot fully excludeWe recently identified the efflux pump in the apical
membrane of human kidney proximal tubules as well the possibility of cell fusion. Our findings contradict
with processes described for repopulation of other tis-(20), where BCRP likely contributes to the excretory
processes of drugs and toxic substances in the urine. The sues, including liver, heart, and Purkinje neurons (3,
47,49); however, they are more in line with reportspresent study shows that assessments of creatinine clear-
ance and fractional sodium excretion after AKI point showing that fusion with resident renal tubular cells can
occur but that it is a rare phenomenon (14,34).toward protection against ischemia-reperfusion injury,
which is in agreement with our earlier findings for P- Enhanced GFP-tagged WT BM cells accounted for
approximately 9% of postischemic kidney remodeling,gp-deficient mice (21). These findings suggest that the
functional absence of BCRP or P-gp attenuate renal in- which is in agreement with previous reports (36,41). We
performed our studies 4 weeks after BM transplantationjury. However, it is not likely that this is caused by alter-
ations in renal function, because BCRP-deficient mice and did not achieve full reconstitution of BM. Peripheral
blood consisted of 55% eGFP-positive donor BM cellsshow no similarities with the renal functional phenotype
of P-gp-deficient mice (21). The bcrp−/− mice show an (not shown), indicating that the remaining 45% is still
from the recipient animal and that the observed contri-increased urine flow and slightly elevated creatinine and
GFR, which is in contrast to P-gp-deficient mice that bution of BM to renal remodeling could be slightly un-
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Figure 4. Enhanced infiltration of eGFP-labeled BM-derived cells in absence of P-gp or BCRP. (A) Representative kidneys from
6 WT-WT transplanted animals show eGFP-positive tubules (green) after 7 days. Staining was performed using an antibody against
GFP (green). Counterstaining was performed with antibodies against Ter-119, an erythrocyte marker (red). Kidneys from 12 P-gp-
WT transplanted animals show infiltration of eGFP-labeled donor bone marrow cells after 2 days (representative for 6 mice), which
further increased after 7 days (representative for 6 mice). Counterstaining of the GFP-positive tubules was performed with an
antibody directed against P-gp (red), and indicates that cells were derived from P-gp-deficient BM. Staining of WT kidneys
confirmed P-gp positivity (not shown). BCRP-WT transplanted animals (n = 6) also showed infiltration after 2 days, which in-
creased after 7 days. Counterstaining (red) with an antibody directed against BCRP confirms the origin of the donor bone marrow-
derived cells (original magnification: ×200, ×400). (B) Overview of kidneys shown in (A) but with lower magnification, after WT-
WT, P-gp-WT, and WT-BCRP transplantations (original magnification ×100). Quantification with confocal microscopy after stain-
ing with antibodies against GFP, in which one green cell accounted for a positive tubule, revealed the amount of eGFP-positive
tubules expressed as percent of total number of tubules. *p < 0.05, ***p < 0.001. (C) Representative Western blot of three indepen-
dent blots loaded with four samples of each treatment confirms increased infiltration of BM-derived eGFP-labeled cells in trans-
planted animals 7 days after ischemia. Relative pixel intensities were determined through image analysis. Data are expressed as
mean ± SEM. *p < 0.05.
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Figure 4. Continued. (D) BM-derived cells do not fuse with resident renal tubular cells. Female BM-derived cells in kidneys after
transplantion of female WT mouse BM in four male WT recipients (indicated with arrows in upper panels). These cells show
exclusively two X chromosomes (green) and no Y chromosome (red). Control images show the specificities of the X and Y
chromosomal paints (original magnification: ×630). (E) Increased amount of MAC-1-positive cells in recipient kidneys transplanted
with knockout BM. MAC-1-positive cells (red) observed in P-gp-WT and BCRP-WT mice compared to WT-WT mice (original
magnification: ×400).
derestimated. Still, the majority of epithelial repopula- Our analyses revealed that BM from P-gp or BCRP
knockout mice contains significantly more myeloid cellstion originates from BM-independent processes. It was
suggested that the most important mechanism of renal (monocytes, granulocytes) and EPCs, which indicates
that modulation of the immune response may be respon-regeneration might occur through survival of dedifferen-
tiated epithelial cells, which proliferate and redifferenti- sible for the regeneration rather than direct tubular dif-
ferentiation. This is supported by recent literature onate into mature functional epithelial cells (10,25). But
this process may also hamper tissue remodeling by fi- macrophage involvement in renal injury and repair
(27,42) and the findings that surviving tubular epithelialbroblast formation, causing renal interstitial fibrosis (13).
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Table 2. BM Constitution in WT, P-gp-Deficient, tests confirmed protection, indicating that P-gp and
and BCRP-Deficient Mice BCRP are potential targets for cell-based therapies in
regenerative medicine. As incomplete recovery of the
P-gp BCRP kidney after AKI may lead to progressive loss of renalWT (%) Deficient (%) Deficient (%)
function over time, novel, effective, treatment for AKI
remains a challenge. A selective knock-down of theLin−, ckit+, Sca-1+ 0.6 ± 0.1 0.6 ± 0.1 0.6 ± 0.02
CD45+, Mac+, Gr+ 37.6 ± 2.3 52.9 ± 4.5* 41.2 ± 1.7 functional expression of P-gp or BCRP in BM cells by
CD45+, Mac+ 39.9 ± 0.6 60.0 ± 6.0* 46.9 ± 0.7† inhibitors or by small interfering RNAs may be a novel
CD45+, Gr+ 37.2 ± 1.9 52.3 ± 5.4* 45.6 ± 1.2‡ pharmacological approach in stem cell-based therapies.
CD45+, CD4+, CD8+ 0.1 ± 0.03 0.2 ± 0.03 0.30 ± 0.03 Systemic inhibition of either efflux pumps after AKI is
CD45+, CD19+, B220+ 15.7 ± 1.2 6.2 ± 0.8* 11.5 ± 0.5 probably less successful due to the resulting accumula-
CD45−, CD31+ 0.1 ± 0.04 0.2 ± 0.1 0.3 ± 0.1 tion of xenobiotics and metabolic waste products.CD45−, CD34+ nd nd nd In conclusion, we found that P-gp or BCRP defi-Sca-1+, CD45− 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1
ciency in BM resulted in accelerated functional andSca-1+, CD45+ 4.5 ± 0.9 3.6 ± 1.0 5.2 ± 1.6
morphological renal response early after ischemia-reper-
Data are expressed as mean ± SEM of six mice. Cells were stained fusion injury, but the later stages of injury repair have
and analyzed using FACS analysis and shown as percentage from total to be studied to fully understand the protective mecha-population of sorted BM. nd, not detectable.
nism in P-gp or BCRP deficiency. Furthermore, we*p < 0.001 compared to WT cells.
†p < 0.05 compared to WT cells. demonstrate that BM from P-gp- or BCRP-deficient
‡p < 0.01 compared to WT cells.
mice contains significantly more monocytes and granu-
locytes as well as early outgrowth endothelial progenitor
cells, potentially fueling renal protection.cells predominantly repair ischemic tubular injury in the
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